Stocks · News reference
Repligen shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 28, 2026, 2:18 PM
- Checked
- Jul 28, 2026, 2:18 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
JP Morgan Maintains Overweight on Repligen, Raises Price Target to $175
Read original at benzingaNasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today
A deepening chip rout drags the Nasdaq while Coca-Cola and Sherwin-Williams beats power the Dow; oil dives 5% on Iran diplomacy as the Fed meets.
Read original at benzinga12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular session. The company's market cap stands at $936.3 million. As per the press release, Q2 earnings came out yesterday.
Read original at benzinga